Lipidomics reveals robust lipid profiling capabilities from tiny plasma samples, suggesting new approaches for research in precision medicine.
Lipidomics provides critical insights into disease mechanisms, biomarker discovery, and precision medicine, but conventional LC-MS workflows often require large sample volumes, limiting their application in minimally invasive studies. Here, we establish a nanoflow liquid chromatography (nanoLC) platform coupled with trapped ion mobility spectrometry and time-of-flight mass spectrometry (TIMS-TOF) for comprehensive lipid profiling from as little as 1 μL of plasma. Two commonly employed single-phase extraction protocols (MeOH:MTBE and IPA:H₂O) were scaled to microsample volumes using NIST® SRM® 1950 plasma, and the influence of mobile phase buffer concentration (10, 5, and 2 mM NH₄HCO₂) on lipid coverage and chromatographic performance was systematically evaluated. Multivariate analysis revealed solvent- and buffer-dependent shifts in lipid distributions, while manual annotation and verification based on ion mobility ensured precise lipid identification, even from small volumes. The optimized nanoLC-TIMS-TOF workflow achieved broad lipid class coverage, enhanced detection of low-abundance species, and improved separation of structurally similar lipids using only 1 μL of starting material. Compared to high-flow LC-MS approaches, similar lipid coverage was achieved at lower buffer concentrations, though ammonium adduct formation introduced distinct lipid-specific biases. These results demonstrate the robustness and scalability of nanoLC-TIMS-MS lipidomics for sample-limited applications.
No takes yet. Share an insight, caveat, or question.
Rellin et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: